Skip to content

    Black Rose Indus

    514183
    Chemicals·7 Feb 2025
    Management Summary

    Black Rose Industries reported strong financial performance in Q3 FY25, driven by significant year-on-year revenue growth and improved EBITDA margins. The company saw a substantial increase in export contributions and maintained a debt-free balance sheet. Strategic initiatives, including new product development and capacity expansion, are progressing, with key R&D and environmental clearance milestones expected soon.

    Highlights

    8
    • Revenue from operations increased by about 48% year-on-year.

    • EBITDA margin improved substantially from about 8% to about 10% in the quarter.

    • Exports contributed 30% to the revenue, up from 18% in the previous quarter.

    • The company reported a healthy 19% return on capital employed.

    • Sales of the new PAM liquid binder product increased by more than 50% from the average monthly sales of the previous quarter.

    • The company remains long-term debt-free.

    • The new R&D center is expected to be completed by the end of Q4 FY25.

    • A new specialty chemical project at Jhagadia has a planned annual turnover of 5,000 metric tons.

    What Changed2

    vs Q4 FY25

    Guidance items7 → 12 (+5)Risks discussed4 → 5 (+1)

    Key financials

    Single quarter

    03 metrics
    1. 01Revenue from Operations+48%YoY
    2. 02EBITDA Margin10%
    3. 03Return on Capital Employed19%

    Segment breakdown

    Distribution Business
    66.7% Share of Revenue30% Export Contribution to Revenue18% Export Contribution (Previous Quarter)93% Top 5 Products Share of Top Line85% Top 5 Products Share of Distribution
    Manufacturing Business
    32,000 metric tons per annum Acrylamide Plant Capacity40,000 metric tons per annum Polyacrylamide Liquids Capacity3,600 metric tons per annum Acrylamide Solids Capacity2,000 metric tons per annum N-methylol Acrylamide (NMA) Capacity
    List

    Capital allocation

    4
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    M&A

    B.R. Chemicals Co. Ltd.

    divestment · closed

    Liquidity

    Liquidity disclosed

    The company has enough funds to take care of its requirements.

    Guidance & targets

    12
    CategoryTargetPriority
    Revenue
    Overall Volume and Revenue Growth
    substantial growth
    Medium
    Sales Volume
    Merchant Sales Volume (Chemical Distribution)
    remain steady
    Medium
    Sales Volume
    Acrylamide Liquid/Solid Exports
    substantial growth
    Medium
    Sales Volume
    PAM Liquid Contribution
    contribute more significantly
    Medium
    Sales Volume
    NMA Export Growth
    main growth from export markets
    Medium
    Project Completion
    New R&D Center Completion
    completed
    High
    Project Completion
    Polyacrylamide Solids Technology Completion
    completed
    High
    Project Completion
    PAM Solids R&D Completion
    completed
    High
    Regulatory Milestone
    New Brownfield Specialty Chemical Project EC Application
    completed
    High
    Commercialization
    PAM Solids Commercialization
    commercialized
    Medium
    Capacity
    New Specialty Chemical Project (Jhagadia) Turnover
    5,000 metric tons per annum
    High
    Profitability
    Manufacturing Margins
    much healthier margin
    Medium

    PAM Solids R&D Completion

    next quarter
    CurrentUnderway, initial technology expected by FY25 end
    TargetCompleted by FY25 end (March 2025)

    Why it matters

    Completion of R&D for this new product is a key milestone for future commercialization and margin improvement.

    I'm assuming you mean by the financial year end and not the calendar year. ... Yes, we mean by the financial year end the initial technology is expected to be completed

    How to verify

    guidance_and_targets[metric='PAM Solids R&D Completion']

    Risks & concerns

    5
    RiskSeverity

    Raw material price volatility (Acrylonitrile)

    Acrylonitrile prices increased by $100 in the current month, but strategic planning helps maintain spreads.Management acknowledged

    medium

    US Tariffs War and geopolitical shifts

    US tariffs on Chinese goods are seen as potentially helping Indian chemical companies, creating export opportunities.Management acknowledged

    low

    China overcapacity and dumping

    Acrylonitrile market has overcapacity due to new Chinese manufacturing, but this is not seen as a challenge for the company's supply.Management acknowledged

    low

    Logistics issues and high freight rates

    Past logistics logjams and high freight rates impacted performance, but the situation is easing, expected to boost volumes.Management acknowledged

    low

    Lack of transparency on new projects and JV partners

    Analysts expressed concern over the lack of specific details on new projects and JV partners, citing confidentiality clauses.Analyst acknowledged

    medium

    Q&A highlights

    8

    “Yes, we mean by the financial year end the initial technology is expected to be completed and then there are further steps which need to be taken before the product is commercialized. So yeah, one part of the technology development is going to be completed by the year. ... So currently we are expecting this to get commercialized towards the end of the upcoming financial year.”

    Clarifies the specific timelines for the completion of R&D and subsequent commercialization of a key new product.

    asked by Hussain Tambawala

    2 min read6 chapters

    Detailed Narrative

    01

    Q3 FY25 Financial Performance Overview

    Black Rose Industries reported a robust Q3 FY25, with revenue from operations increasing by approximately 48% year-on-year, despite a minor quarter-on-quarter dip. The company's EBITDA margin saw a substantial improvement, rising from about 8% to 10% in the quarter, reflecting healthy growth. Furthermore, the return on capital employed stood at a healthy 19%, indicating efficient use of capital.

    02

    Segmental Performance and Export Dynamics

    The distribution business maintained a steady top line, contributing around two-thirds of the company's total revenue, with improved operational margins due to better planning. Exports played a crucial role, contributing 30% to the total revenue, a significant increase from 18% in the previous quarter, primarily driven by a rebound in the US oil and gas sector. The top five products in the distribution business accounted for 93% of the top line and 85% of the distribution segment.

    03

    Manufacturing Division and Product-Specific Growth

    The manufacturing division experienced stable demand and improved margins, particularly for acrylamide liquid, attributed to strategic raw material procurement and efficient logistics. The new PAM liquid binder product has been well-accepted, leading to a sales increase of over 50% from the average monthly sales of the previous quarter. The company is also actively expanding its N-methylol acrylamide (NMA) exports, anticipating significant growth from international markets.

    04

    Strategic Projects and R&D Initiatives

    Black Rose Industries is progressing on several key strategic initiatives. The new R&D center is slated for completion by the end of the current quarter (Q4 FY25), which will enhance R&D capabilities. The polyacrylamide solids technology is expected to be completed by the end of the calendar year 2025. Additionally, the final application for environmental clearance for a new brownfield specialty chemical project is being completed this week, and the company is securing land in Dahej for future projects.

    05

    Raw Material and Logistics Outlook

    Raw material prices for acrylonitrile increased by $100 in the current month, but the company's strategic planning helps maintain healthy spreads and margins. The international logistics situation is improving, with freight rates decreasing, which is expected to substantially increase export orders in the current quarter. Management views the US tariffs on Chinese goods as a potential opportunity for Indian chemical manufacturers, despite global overcapacity in acrylonitrile.

    06

    Capital Structure and Subsidiary Consolidation

    The company continues to maintain a long-term debt-free status with a negligible debt-equity ratio, indicating a strong financial position. It possesses sufficient funds to meet its operational and strategic requirements. In a move to enhance consolidated cash flow and profitability, the operations of its subsidiary, B.R. Chemicals Co. Ltd., were closed effective January 30, 2025, after fulfilling its primary objectives.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.